Study design

retrospective

Study time

2019.4-2020.3

Country

China

Object

A total of 56 consecutive patients diagnosed with localized prostate cancer based on clinical characteristics, prostate biopsy results, prostate-specific antigen (PSA) levels, and imaging studies were included at Changzheng Hospital in Shanghai, Chi. These patients underwent extraperitoneal RARP with the da Vinci Si Surgical System (Intuitive Surgical, Sunnyvale, CA, USA). Thirty patients underwent single-port surgery (SP group), and 26 patients underwent multiport surgery (MP group)

Inclusion criteria

Exclusion criteria included a previous infraumbilical midline incision, body mass index (BMI) >40 kg m−2, preoperative PSA level >20 ng ml−1, biopsy Gleason score >7, prior prostate treatment, or preoperative evidence of extraprostatic disease.

Robots remarks

The da Vinci Si Surgical System (Intuitive Surgical) was used to perform RP. For the SP group, the scope holder arm and two primary robotic arms were used, while the fourth secondary arm was not used

Sample size

56

Topic classification

Focus on RARP

Keypoint

Extraperitoneal robotic single-port radical prostatectomy can be a treatment option for localized prostate cancer. Although it still has a learning curve, it has advantages for postoperative pain and self-assessed cosmesis.

Year